Pharma Friday – October 16, 2026

Published on October 16, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children On October 16, Ascendis Pharma A/S announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a […]

The post Pharma Friday – October 16, 2026 appeared first on Endocrine News.

Continue reading on website
Other news

Inaugural EndoForum Live 2027 to Present the Best of Society’s SIGs

October 15, 2026
It’s one of my favorite member benefits. The Society’s Special Interest Groups – or SIGs as they’re affectionately known – bring together peers from around the world who share common clinical, research, or career interests. Each year, the 12 existing SIGs (see list below) offer a broad range of educational and networking opportunities, including widely […]The post Inaugural EndoForum Live 2027 to